摘要
先天性中性粒细胞减少症是一组异质性疾病,重型先天性中性粒细胞减少症(SCN)自发现至今已有50余年。近年来的一系列研究已在分子水平上阐明了某些患者的发病机制,如SCN中最常见的ELA2基因突变及其引发的未折叠蛋白反应;HAX1、GFI1、WAS等基因突变所致SCN等。这使先天性中性粒细胞减少症患者的进一步分型诊断成为可能,从而为今后相应的靶向治疗提供了理论依据。
Congenital neutropenia comprises a variety of genetically heterogeneous phenotypic traits.Severe congenital neutropenia(SCN)has been discovered for over five decades.In recent years,a series of molecular studies identified the pathomechanisms in some patients,such as mutations in ELA2 gene that is most frequently occurring and causing unfolded protein response,HAX1,GFI1,and WAS.Such findings make it possible to further classify congenital neutropenia and serve as the theoretical foundation for prospective targeted therapy.
出处
《医学综述》
2010年第24期3743-3746,共4页
Medical Recapitulate